Roles of cytotoxic and helper innate lymphoid cells in cancer

Natural killer (NK) cells have long been recognized for their anti-cancer activity and are now included in the large family of innate lymphoid cells (ILCs). The discovery of new ILC subsets that, similarly to NK cells, are able to kill tumor cells encourages us to redefine NK cell role in anti-tumor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mammalian genome 2018-12, Vol.29 (11-12), p.777-789
1. Verfasser: Guillerey, Camille
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 789
container_issue 11-12
container_start_page 777
container_title Mammalian genome
container_volume 29
creator Guillerey, Camille
description Natural killer (NK) cells have long been recognized for their anti-cancer activity and are now included in the large family of innate lymphoid cells (ILCs). The discovery of new ILC subsets that, similarly to NK cells, are able to kill tumor cells encourages us to redefine NK cell role in anti-tumor immunity. Conventional NK cells circulate through the blood and screen the body for “stressed” cells. Therefore, NK cells are believed to play a key role in cancer immunosurveillance by the early elimination of cells undergoing malignant transformation. Tissue-resident ILCs might play a similar role since they are ideally located to detect the early signs of malignant transformation in their organ of residence. We are only beginning to appreciate the importance of the whole ILC family in cancer. Confusingly, these cells have been reported to both inhibit and fuel cancer progression and the factors regulating these dual functions remain unclear. Here, I review the recent advances in our understanding of cytotoxic and cytokine-producing helper ILC subsets in cancer.
doi_str_mv 10.1007/s00335-018-9781-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2099434081</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2098886402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f4b31e46e6e19459fd8e62eed2dcc05b3e01b7d5e928ec2139d4d2ee29d252693</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBdZ8OJldfKxm-TgQYpfUBBEz2GbzNot201NdsH-e1PqBwieJsw882Z4CDmlcEkB5FUE4LzIgapcS0VzsUfGVHCWUynlPhmD5ipXWsOIHMW4BKCypPKQjHh6KQ7lmFw_-xZj5uvMbnrf-4_GZlXnsgW2awxZ03VVj1m7Wa0XvnGZxbaNqZvZqrMYjslBXbURT77qhLze3b5MH_LZ0_3j9GaWWy5Zn9dizimKEkukWhS6dgpLhuiYsxaKOUegc-kK1EyhZZRrJ1yaM-1YwUrNJ-Ril7sO_n3A2JtVE7e3VB36IRoGWgsuQNGEnv9Bl34IXbpuSymlSgEsUXRH2eBjDFibdWhWVdgYCmbr1uzcmuTWbN0akXbOvpKH-Qrdz8a3zASwHRDTqHvD8Pv1_6mfBRKC2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2098886402</pqid></control><display><type>article</type><title>Roles of cytotoxic and helper innate lymphoid cells in cancer</title><source>SpringerNature Journals</source><creator>Guillerey, Camille</creator><creatorcontrib>Guillerey, Camille</creatorcontrib><description>Natural killer (NK) cells have long been recognized for their anti-cancer activity and are now included in the large family of innate lymphoid cells (ILCs). The discovery of new ILC subsets that, similarly to NK cells, are able to kill tumor cells encourages us to redefine NK cell role in anti-tumor immunity. Conventional NK cells circulate through the blood and screen the body for “stressed” cells. Therefore, NK cells are believed to play a key role in cancer immunosurveillance by the early elimination of cells undergoing malignant transformation. Tissue-resident ILCs might play a similar role since they are ideally located to detect the early signs of malignant transformation in their organ of residence. We are only beginning to appreciate the importance of the whole ILC family in cancer. Confusingly, these cells have been reported to both inhibit and fuel cancer progression and the factors regulating these dual functions remain unclear. Here, I review the recent advances in our understanding of cytotoxic and cytokine-producing helper ILC subsets in cancer.</description><identifier>ISSN: 0938-8990</identifier><identifier>EISSN: 1432-1777</identifier><identifier>DOI: 10.1007/s00335-018-9781-4</identifier><identifier>PMID: 30178306</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animal Genetics and Genomics ; Biomedical and Life Sciences ; Cancer ; Cell Biology ; Cytotoxicity ; Human Genetics ; Immunosurveillance ; Life Sciences ; Lymphoid cells ; Natural killer cells ; Tumor cells</subject><ispartof>Mammalian genome, 2018-12, Vol.29 (11-12), p.777-789</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><rights>Mammalian Genome is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-f4b31e46e6e19459fd8e62eed2dcc05b3e01b7d5e928ec2139d4d2ee29d252693</citedby><cites>FETCH-LOGICAL-c372t-f4b31e46e6e19459fd8e62eed2dcc05b3e01b7d5e928ec2139d4d2ee29d252693</cites><orcidid>0000-0002-7917-2432</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00335-018-9781-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00335-018-9781-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30178306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guillerey, Camille</creatorcontrib><title>Roles of cytotoxic and helper innate lymphoid cells in cancer</title><title>Mammalian genome</title><addtitle>Mamm Genome</addtitle><addtitle>Mamm Genome</addtitle><description>Natural killer (NK) cells have long been recognized for their anti-cancer activity and are now included in the large family of innate lymphoid cells (ILCs). The discovery of new ILC subsets that, similarly to NK cells, are able to kill tumor cells encourages us to redefine NK cell role in anti-tumor immunity. Conventional NK cells circulate through the blood and screen the body for “stressed” cells. Therefore, NK cells are believed to play a key role in cancer immunosurveillance by the early elimination of cells undergoing malignant transformation. Tissue-resident ILCs might play a similar role since they are ideally located to detect the early signs of malignant transformation in their organ of residence. We are only beginning to appreciate the importance of the whole ILC family in cancer. Confusingly, these cells have been reported to both inhibit and fuel cancer progression and the factors regulating these dual functions remain unclear. Here, I review the recent advances in our understanding of cytotoxic and cytokine-producing helper ILC subsets in cancer.</description><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cytotoxicity</subject><subject>Human Genetics</subject><subject>Immunosurveillance</subject><subject>Life Sciences</subject><subject>Lymphoid cells</subject><subject>Natural killer cells</subject><subject>Tumor cells</subject><issn>0938-8990</issn><issn>1432-1777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kE1LAzEQhoMotlZ_gBdZ8OJldfKxm-TgQYpfUBBEz2GbzNot201NdsH-e1PqBwieJsw882Z4CDmlcEkB5FUE4LzIgapcS0VzsUfGVHCWUynlPhmD5ipXWsOIHMW4BKCypPKQjHh6KQ7lmFw_-xZj5uvMbnrf-4_GZlXnsgW2awxZ03VVj1m7Wa0XvnGZxbaNqZvZqrMYjslBXbURT77qhLze3b5MH_LZ0_3j9GaWWy5Zn9dizimKEkukWhS6dgpLhuiYsxaKOUegc-kK1EyhZZRrJ1yaM-1YwUrNJ-Ril7sO_n3A2JtVE7e3VB36IRoGWgsuQNGEnv9Bl34IXbpuSymlSgEsUXRH2eBjDFibdWhWVdgYCmbr1uzcmuTWbN0akXbOvpKH-Qrdz8a3zASwHRDTqHvD8Pv1_6mfBRKC2w</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Guillerey, Camille</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7917-2432</orcidid></search><sort><creationdate>20181201</creationdate><title>Roles of cytotoxic and helper innate lymphoid cells in cancer</title><author>Guillerey, Camille</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f4b31e46e6e19459fd8e62eed2dcc05b3e01b7d5e928ec2139d4d2ee29d252693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cytotoxicity</topic><topic>Human Genetics</topic><topic>Immunosurveillance</topic><topic>Life Sciences</topic><topic>Lymphoid cells</topic><topic>Natural killer cells</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guillerey, Camille</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Mammalian genome</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guillerey, Camille</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Roles of cytotoxic and helper innate lymphoid cells in cancer</atitle><jtitle>Mammalian genome</jtitle><stitle>Mamm Genome</stitle><addtitle>Mamm Genome</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>29</volume><issue>11-12</issue><spage>777</spage><epage>789</epage><pages>777-789</pages><issn>0938-8990</issn><eissn>1432-1777</eissn><abstract>Natural killer (NK) cells have long been recognized for their anti-cancer activity and are now included in the large family of innate lymphoid cells (ILCs). The discovery of new ILC subsets that, similarly to NK cells, are able to kill tumor cells encourages us to redefine NK cell role in anti-tumor immunity. Conventional NK cells circulate through the blood and screen the body for “stressed” cells. Therefore, NK cells are believed to play a key role in cancer immunosurveillance by the early elimination of cells undergoing malignant transformation. Tissue-resident ILCs might play a similar role since they are ideally located to detect the early signs of malignant transformation in their organ of residence. We are only beginning to appreciate the importance of the whole ILC family in cancer. Confusingly, these cells have been reported to both inhibit and fuel cancer progression and the factors regulating these dual functions remain unclear. Here, I review the recent advances in our understanding of cytotoxic and cytokine-producing helper ILC subsets in cancer.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30178306</pmid><doi>10.1007/s00335-018-9781-4</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-7917-2432</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0938-8990
ispartof Mammalian genome, 2018-12, Vol.29 (11-12), p.777-789
issn 0938-8990
1432-1777
language eng
recordid cdi_proquest_miscellaneous_2099434081
source SpringerNature Journals
subjects Animal Genetics and Genomics
Biomedical and Life Sciences
Cancer
Cell Biology
Cytotoxicity
Human Genetics
Immunosurveillance
Life Sciences
Lymphoid cells
Natural killer cells
Tumor cells
title Roles of cytotoxic and helper innate lymphoid cells in cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Roles%20of%20cytotoxic%20and%20helper%20innate%20lymphoid%20cells%20in%20cancer&rft.jtitle=Mammalian%20genome&rft.au=Guillerey,%20Camille&rft.date=2018-12-01&rft.volume=29&rft.issue=11-12&rft.spage=777&rft.epage=789&rft.pages=777-789&rft.issn=0938-8990&rft.eissn=1432-1777&rft_id=info:doi/10.1007/s00335-018-9781-4&rft_dat=%3Cproquest_cross%3E2098886402%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2098886402&rft_id=info:pmid/30178306&rfr_iscdi=true